Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedStatus on the study page updated to 'Results Submitted' from 'No Results Posted'. This indicates the trial's results have been submitted for review and will appear in the results section.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6. This indicates a minor update to the page's version metadata rather than any content changes.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a minor platform update to the page that does not change study content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe site revision was updated from v3.6.3 to v3.6.4, signalling a maintenance/version update to the ClinicalTrials.gov page infrastructure. The update does not modify the study details, eligibility criteria, or other content presented on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. This change does not modify study data, eligibility criteria, or results.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a small internal update to the page's version history. This change does not modify the public study content or visible information.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.